Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma.

Pazina T, James AM, Colby KB, Yang Y, Gale A, Jhatakia A, Kearney AY, Graziano RF, Bezman NA, Robbins MD, Cohen AD, Campbell KS.

Cancer Immunol Res. 2019 Oct;7(10):1633-1646. doi: 10.1158/2326-6066.CIR-18-0579. Epub 2019 Aug 20.

PMID:
31431433
2.

Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab.

Kurdi AT, Glavey SV, Bezman NA, Jhatakia A, Guerriero JL, Manier S, Moschetta M, Mishima Y, Roccaro A, Detappe A, Liu CJ, Sacco A, Huynh D, Tai YT, Robbins MD, Azzi J, Ghobrial IM.

Mol Cancer Ther. 2018 Jul;17(7):1454-1463. doi: 10.1158/1535-7163.MCT-17-0998. Epub 2018 Apr 13.

3.

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models.

Bezman NA, Jhatakia A, Kearney AY, Brender T, Maurer M, Henning K, Jenkins MR, Rogers AJ, Neeson PJ, Korman AJ, Robbins MD, Graziano RF.

Blood Adv. 2017 May 8;1(12):753-765. doi: 10.1182/bloodadvances.2017004382. eCollection 2017 May 9.

4.

Association of candidate genes with heading date in a diverse Dactylis glomerata population.

Zhao X, Bushman BS, Zhang X, Robbins MD, Larson SR, Robins JG, Thomas A.

Plant Sci. 2017 Dec;265:146-153. doi: 10.1016/j.plantsci.2017.10.002. Epub 2017 Oct 7.

PMID:
29223336
5.

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

Pazina T, James AM, MacFarlane AW 4th, Bezman NA, Henning KA, Bee C, Graziano RF, Robbins MD, Cohen AD, Campbell KS.

Oncoimmunology. 2017 Jun 16;6(9):e1339853. doi: 10.1080/2162402X.2017.1339853. eCollection 2017.

6.

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.

Anderson KC, Auclair D, Kelloff GJ, Sigman CC, Avet-Loiseau H, Farrell AT, Gormley NJ, Kumar SK, Landgren O, Munshi NC, Cavo M, Davies FE, Di Bacco A, Dickey JS, Gutman SI, Higley HR, Hussein MA, Jessup JM, Kirsch IR, Little RF, Loberg RD, Lohr JG, Mukundan L, Omel JL, Pugh TJ, Reaman GH, Robbins MD, Sasser AK, Valente N, Zamagni E.

Clin Cancer Res. 2017 Aug 1;23(15):3980-3993. doi: 10.1158/1078-0432.CCR-16-2895. Epub 2017 Apr 20.

7.

Phylogenetic relationships among low-ploidy species of Poa using chloroplast sequences.

Joshi A, Bushman BS, Pickett B, Robbins MD, Staub JE, Johnson PG.

Genome. 2017 May;60(5):384-392. doi: 10.1139/gen-2016-0110. Epub 2016 Nov 23.

PMID:
28177839
8.

Molecular and morphological evidence for Penstemon luculentus (Plantaginaceae): a replacement name for Penstemon fremontii var. glabrescens.

Johnson RL, Stevens MR, Johnson LA, Robbins MD, Anderson CD, Ricks NJ, Farley KM.

PhytoKeys. 2016 May 20;(63):47-62. doi: 10.3897/phytokeys.63.7952. eCollection 2016.

9.

Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab.

Postelnek J, Neely RJ, Robbins MD, Gleason CR, Peterson JE, Piccoli SP.

AAPS J. 2016 Jul;18(4):989-99. doi: 10.1208/s12248-016-9912-3. Epub 2016 Apr 26.

PMID:
27116021
10.

Association Analysis for Bacterial Spot Resistance in a Directionally Selected Complex Breeding Population of Tomato.

Sim SC, Robbins MD, Wijeratne S, Wang H, Yang W, Francis DM.

Phytopathology. 2015 Nov;105(11):1437-45. doi: 10.1094/PHYTO-02-15-0051-R. Epub 2015 Oct 28.

11.

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways.

Balasa B, Yun R, Belmar NA, Fox M, Chao DT, Robbins MD, Starling GC, Rice AG.

Cancer Immunol Immunother. 2015 Jan;64(1):61-73. doi: 10.1007/s00262-014-1610-3. Epub 2014 Oct 7.

12.

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.

Munchhof MJ, Li Q, Shavnya A, Borzillo GV, Boyden TL, Jones CS, LaGreca SD, Martinez-Alsina L, Patel N, Pelletier K, Reiter LA, Robbins MD, Tkalcevic GT.

ACS Med Chem Lett. 2011 Dec 21;3(2):106-11. doi: 10.1021/ml2002423. eCollection 2012 Feb 9.

13.

Molecular mapping of hypersensitive resistance from tomato 'Hawaii 7981' to Xanthomonas perforans race T3.

Wang H, Hutton SF, Robbins MD, Sim SC, Scott JW, Yang W, Jones JB, Francis DM.

Phytopathology. 2011 Oct;101(10):1217-23. doi: 10.1094/PHYTO-12-10-0345.

14.

Mapping and linkage disequilibrium analysis with a genome-wide collection of SNPs that detect polymorphism in cultivated tomato.

Robbins MD, Sim SC, Yang W, Van Deynze A, van der Knaap E, Joobeur T, Francis DM.

J Exp Bot. 2011 Mar;62(6):1831-45. doi: 10.1093/jxb/erq367. Epub 2010 Dec 30.

15.

Population structure and genetic differentiation associated with breeding history and selection in tomato (Solanum lycopersicum L.).

Sim SC, Robbins MD, Van Deynze A, Michel AP, Francis DM.

Heredity (Edinb). 2011 Jun;106(6):927-35. doi: 10.1038/hdy.2010.139. Epub 2010 Nov 17.

16.

Stopped-flow kinetic analysis using Hadamard transform time-of-flight mass spectrometry.

Robbins MD, Yoon OK, Barbula GK, Zare RN.

Anal Chem. 2010 Oct 15;82(20):8650-7. doi: 10.1021/ac101899n.

PMID:
20843011
17.

Tomato Analyzer: a useful software application to collect accurate and detailed morphological and colorimetric data from two-dimensional objects.

Rodríguez GR, Moyseenko JB, Robbins MD, Morejón NH, Francis DM, van der Knaap E.

J Vis Exp. 2010 Mar 16;(37). pii: 1856. doi: 10.3791/1856.

18.

Oligonucleotide array discovery of polymorphisms in cultivated tomato (Solanum lycopersicum L.) reveals patterns of SNP variation associated with breeding.

Sim SC, Robbins MD, Chilcott C, Zhu T, Francis DM.

BMC Genomics. 2009 Oct 9;10:466. doi: 10.1186/1471-2164-10-466.

19.

Desorption electrospray ionization: achieving rapid sampling rates.

Barbula GK, Robbins MD, Yoon OK, Zuleta I, Zare RN.

Anal Chem. 2009 Nov 1;81(21):9035-40. doi: 10.1021/ac901668a.

PMID:
19778033
20.

Characterization of hypersensitive resistance to bacterial spot race T3 (Xanthomonas perforans) from tomato accession PI 128216.

Robbins MD, Darrigues A, Sim SC, Masud MA, Francis DM.

Phytopathology. 2009 Sep;99(9):1037-44. doi: 10.1094/PHYTO-99-9-1037.

21.

Comparative analysis of marker-assisted and phenotypic selection for yield components in cucumber.

Robbins MD, Staub JE.

Theor Appl Genet. 2009 Aug;119(4):621-34. doi: 10.1007/s00122-009-1072-8. Epub 2009 May 31.

PMID:
19484431
22.

Continuous time-of-flight ion imaging: application to fragmentation.

Yoon OK, Robbins MD, Zuleta IA, Barbula GK, Zare RN.

Anal Chem. 2008 Nov 1;80(21):8299-307. doi: 10.1021/ac801512n. Epub 2008 Oct 7.

PMID:
18837560
23.

Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals.

Hawkins JL, Robbins MD, Warren LC, Xia D, Petras SF, Valentine JJ, Varghese AH, Wang IK, Subashi TA, Shelly LD, Hay BA, Landschulz KT, Geoghegan KF, Harwood HJ Jr.

J Pharmacol Exp Ther. 2008 Sep;326(3):801-8. doi: 10.1124/jpet.108.139626. Epub 2008 Jun 24.

PMID:
18577702
24.

Computer-controlled, variable-frequency power supply for driving multipole ion guides.

Robbins MD, Yoon OK, Zuleta I, Barbula GK, Zare RN.

Rev Sci Instrum. 2008 Mar;79(3):034702. doi: 10.1063/1.2884148.

PMID:
18377035
25.

Micromachined Bradbury-Nielsen gates.

Zuleta IA, Barbula GK, Robbins MD, Yoon OK, Zare RN.

Anal Chem. 2007 Dec 1;79(23):9160-5. Epub 2007 Oct 30.

PMID:
17966990
26.

Simple template-based method to produce Bradbury-Nielsen gates.

Yoon OK, Zuleta IA, Robbins MD, Barbula GK, Zare RN.

J Am Soc Mass Spectrom. 2007 Nov;18(11):1901-8. Epub 2007 Aug 3. Erratum in: J Am Soc Mass Spectrom. 2008 Dec;19(12):1948.

27.

Aminopyrrolidineamide inhibitors of site-1 protease.

Hay BA, Abrams B, Zumbrunn AY, Valentine JJ, Warren LC, Petras SF, Shelly LD, Xia A, Varghese AH, Hawkins JL, Van Camp JA, Robbins MD, Landschulz K, Harwood HJ Jr.

Bioorg Med Chem Lett. 2007 Aug 15;17(16):4411-4. Epub 2007 Jun 10.

PMID:
17583500
28.
29.

Duty cycle and modulation efficiency of two-channel Hadamard transform time-of-flight mass spectrometry.

Yoon OK, Zuleta IA, Kimmel JR, Robbins MD, Zare RN.

J Am Soc Mass Spectrom. 2005 Nov;16(11):1888-901. Epub 2005 Sep 29.

30.

Construction of two BAC libraries from cucumber (Cucumis sativus L.) and identification of clones linked to yield component quantitative trait loci.

Nam YW, Lee JR, Song KH, Lee MK, Robbins MD, Chung SM, Staub JE, Zhang HB.

Theor Appl Genet. 2005 Jun;111(1):150-61. Epub 2005 Apr 30.

PMID:
15864523
31.

The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A.

Chuang E, Fisher TS, Morgan RW, Robbins MD, Duerr JM, Vander Heiden MG, Gardner JP, Hambor JE, Neveu MJ, Thompson CB.

Immunity. 2000 Sep;13(3):313-22.

32.

Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases.

Chuang E, Lee KM, Robbins MD, Duerr JM, Alegre ML, Hambor JE, Neveu MJ, Bluestone JA, Thompson CB.

J Immunol. 1999 Feb 1;162(3):1270-7.

34.

Choice as the basis for mentation.

Robbins MD.

Int J Psychoanal. 1984;65 ( Pt 3):365-6. No abstract available.

PMID:
6571613
35.

Borderline personality organization: the need for a new theory.

Robbins MD.

J Am Psychoanal Assoc. 1976;24(4):831-53. No abstract available.

PMID:
993564
36.

On the psychology of artistic creativity.

Robbins MD.

Psychoanal Study Child. 1969;24:227-51. No abstract available.

PMID:
5353365
37.

What parents expect the institution to do for their children.

ROBBINS MD.

Am J Ment Defic. 1957 Apr;61(4):672-4. No abstract available.

PMID:
13410977

Supplemental Content

Loading ...
Support Center